SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 1991. Upgrade now.
Date Value
March 31, 2024 241.48M
December 31, 2023 229.05M
September 30, 2023 224.73M
June 30, 2023 230.20M
March 31, 2023 217.90M
December 31, 2022 214.98M
September 30, 2022 213.78M
June 30, 2022 211.74M
March 31, 2022 210.24M
December 31, 2021 211.92M
September 30, 2021 206.53M
June 30, 2021 192.36M
March 31, 2021 185.58M
December 31, 2020 185.63M
September 30, 2020 213.23M
June 30, 2020 154.45M
March 31, 2020 181.96M
December 31, 2019 180.36M
September 30, 2019 170.89M
June 30, 2019 161.32M
March 31, 2019 166.94M
December 31, 2018 154.88M
September 30, 2018 159.10M
June 30, 2018 157.34M
March 31, 2018 161.03M
Date Value
December 31, 2017 145.86M
September 30, 2017 146.00M
June 30, 2017 143.15M
March 31, 2017 140.16M
December 31, 2016 131.38M
September 30, 2016 132.60M
June 30, 2016 130.97M
March 31, 2016 129.12M
December 31, 2015 125.29M
September 30, 2015 119.30M
June 30, 2015 120.14M
March 31, 2015 117.74M
December 31, 2014 122.50M
September 30, 2014 116.30M
June 30, 2014 109.87M
March 31, 2014 108.94M
December 31, 2013 104.84M
September 30, 2013 98.73M
June 30, 2013 96.75M
March 31, 2013 101.03M
December 31, 2012 84.57M
September 30, 2012 87.37M
June 30, 2012 88.81M
March 31, 2012 93.81M
December 31, 2011 83.38M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

154.45M
Minimum
Jun 2020
241.48M
Maximum
Mar 2024
201.92M
Average
210.99M
Median

SG&A Expense (Quarterly) Benchmarks

Stryker Corp 1.84B
Haemonetics Corp 111.71M
ResMed Inc 229.92M
Steris PLC 360.52M
Zoetis Inc 547.00M